Roby Thomas

413 total citations
21 papers, 266 citations indexed

About

Roby Thomas is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Roby Thomas has authored 21 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Roby Thomas's work include Colorectal Cancer Treatments and Studies (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Cancer survivorship and care (3 papers). Roby Thomas is often cited by papers focused on Colorectal Cancer Treatments and Studies (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Cancer survivorship and care (3 papers). Roby Thomas collaborates with scholars based in United States, Türkiye and Ireland. Roby Thomas's co-authors include Steffi Oesterreich, Adrian V. Lee, Adam Brufsky, Shannon L. Puhalla, José Pablo Leone, Leonie S. Young, Ronald L. Hamilton, Peter C. Lucas, Azadeh Nasrazadani and Rebecca Watters and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and PLoS Computational Biology.

In The Last Decade

Roby Thomas

19 papers receiving 265 citations

Peers

Roby Thomas
Pedro Exman United States
Marc Beishon Italy
Alberto Alvarado‐Miranda Mexico
Nancy Nixon Canada
Arielle J. Medford United States
Giulia Buzzatti Italy
Croix C. Fossum United States
Alexey Moisseev Russia
Nicoletta Provinciali Italy
A Pedrazzini Switzerland
Pedro Exman United States
Roby Thomas
Citations per year, relative to Roby Thomas Roby Thomas (= 1×) peers Pedro Exman

Countries citing papers authored by Roby Thomas

Since Specialization
Citations

This map shows the geographic impact of Roby Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roby Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roby Thomas more than expected).

Fields of papers citing papers by Roby Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roby Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roby Thomas. The network helps show where Roby Thomas may publish in the future.

Co-authorship network of co-authors of Roby Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Roby Thomas. A scholar is included among the top collaborators of Roby Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roby Thomas. Roby Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Low, Carissa A., et al.. (2025). Consumer Wearable Device Measures of Gait Cadence and Activity Fragmentation as Predictors of Survival Among Patients Undergoing Chemotherapy. JCO Clinical Cancer Informatics. 9(9). e2500111–e2500111.
2.
Schenker, Yael, Tianxiu Wang, Rebecca L. Sudore, et al.. (2025). Facilitated Versus Patient-Directed Advance Care Planning Among Patients With Advanced Cancer: A Randomized Clinical Trial. JCO Oncology Practice. 21(10). 1447–1457. 1 indexed citations
3.
Şahin, İbrahim Halil, Turçin Saridogan, Rüveyda Ayasun, et al.. (2024). Targeting KRAS Oncogene for Patients With Colorectal Cancer: A New Step Toward Precision Medicine. JCO Oncology Practice. 20(10). 1336–1347. 7 indexed citations
4.
Şahin, İbrahim Halil, Sakti Chakrabarti, Tullia C. Bruno, et al.. (2024). Combining low-dose regorafenib with pembrolizumab for patients with MSI-H colorectal cancer: REGPEM-CRC-01.. Journal of Clinical Oncology. 42(3_suppl). TPS238–TPS238.
5.
Şahin, İbrahim Halil, Janie Y. Zhang, Turçin Saridogan, et al.. (2023). Neoadjuvant Immune Checkpoint Inhibitor Therapy for Patients With Microsatellite Instability-High Colorectal Cancer: Shedding Light on the Future. JCO Oncology Practice. 19(5). 251–259. 17 indexed citations
6.
Haghshenas, Ehsan, et al.. (2023). Abstract 1400: Novel expression biomarkers via prediction of response to FOLFIRINOX (FFX) treatment for PDAC. Cancer Research. 83(7_Supplement). 1400–1400. 1 indexed citations
7.
Augustin, Ryan C., Andrew Poklepovic, Xin Gao, et al.. (2022). 588 Phase Ib study of the p38 inhibitor ARRY-614 with nivolumab, ipilimumab or nivolumab+ipilimumab in advanced solid tumors. Regular and Young Investigator Award Abstracts. A615–A615. 1 indexed citations
8.
Satturwar, Swati, Anil V. Parwani, Roby Thomas, et al.. (2022). The osteoclast-type giant cell rich carcinoma of urinary bladder: A case series. Pathology - Research and Practice. 239. 154164–154164. 5 indexed citations
9.
10.
Grivas, Petros, Lesli A. Kiedrowski, Guru Sonpavde, et al.. (2021). Spectrum of FGFR2/3 Alterations in Cell-Free DNA of Patients with Advanced Urothelial Carcinoma. Bladder Cancer. 7(2). 143–148. 3 indexed citations
11.
Thomas, Roby, Ellis Levine, Adam Brufsky, et al.. (2020). Outcome of Everolimus-Based Therapy in Hormone-Receptor-Positive Metastatic Breast Cancer Patients After Progression on Palbociclib. Breast Cancer Basic and Clinical Research. 14. 2222502368–2222502368. 27 indexed citations
12.
Brown, Aaron, et al.. (2020). Prognostic value of the “surprise question” among UPMC Hillman Cancer Center patients with select stage IV cancer diagnoses.. Journal of Clinical Oncology. 38(29_suppl). 25–25. 2 indexed citations
13.
Ruffalo, Matthew, Roby Thomas, Jian Chen, et al.. (2019). Network-guided prediction of aromatase inhibitor response in breast cancer. PLoS Computational Biology. 15(2). e1006730–e1006730. 5 indexed citations
14.
Nasrazadani, Azadeh, Roby Thomas, Steffi Oesterreich, & Adrian V. Lee. (2018). Precision Medicine in Hormone Receptor-Positive Breast Cancer. Frontiers in Oncology. 8. 144–144. 29 indexed citations
15.
Thomas, Roby, Ellis Levine, Adam Brufsky, et al.. (2018). Outcome of everolimus based therapy in hormone receptor positive metastatic breast cancer patients after progression on palbociclib combination.. Journal of Clinical Oncology. 36(15_suppl). 1064–1064. 1 indexed citations
16.
Priedigkeit, Nolan, Ryan J. Hartmaier, Yijing Chen, et al.. (2016). Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases. JAMA Oncology. 3(5). 666–666. 118 indexed citations
17.
Thomas, Roby, et al.. (2015). Drug-induced immune hemolytic anemia associated with albumin-bound paclitaxel. The Journal of Community and Supportive Oncology. 13(8). 298–299. 4 indexed citations
18.
Thomas, Roby, et al.. (2015). Palliative Care Training during Fellowship: A National Survey of U.S. Hematology and Oncology Fellows. Journal of Palliative Medicine. 18(9). 747–751. 32 indexed citations
19.
Thomas, Roby, et al.. (2014). Head and neck squamous cell carcinoma (HNSCC), diabetes mellitus (DM), and metformin.. Journal of Clinical Oncology. 32(15_suppl). e17040–e17040. 2 indexed citations
20.
Jackson, Richard J., Donna Johnson, R. Todd Maxson, Roby Thomas, & Samuel D. Smith. (2000). A comparison of neonatal and adult multiorgan failure in a rat model. Journal of Pediatric Surgery. 35(3). 428–431. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pedro Exman Breakdown of academic impact, for papers by Marc Beishon Breakdown of academic impact, for papers by Alberto Alvarado‐Miranda Breakdown of academic impact, for papers by Nancy Nixon Breakdown of academic impact, for papers by Arielle J. Medford Breakdown of academic impact, for papers by Giulia Buzzatti Breakdown of academic impact, for papers by Croix C. Fossum Breakdown of academic impact, for papers by Alexey Moisseev Breakdown of academic impact, for papers by Nicoletta Provinciali Breakdown of academic impact, for papers by A Pedrazzini
Rankless by CCL
2026